| Clara Sanders, MD | |
|
21 John St, #1, Newton, MA 02459-2347 | |
| (978) 516-8876 | |
| Not Available |
| Full Name | Clara Sanders |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 21 John St, Newton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104146935 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | LP02000 (Rhode Island) | Secondary |
| 207L00000X | Anesthesiology | 257186 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Medical Center | Springfield, MA | Hospital |
| Baystate Franklin Medical Center | Greenfield, MA | Hospital |
| Baystate Noble Hospital | Westfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Springfield Anesthesia Service Inc | 0345228011 | 84 |
News Archive
Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at several dozen other domestic and international sites.
A study published today in the journal Cell Reports sheds new light on how the CD2AP gene may enhance Alzheimer's disease susceptibility.
The federal government must renew funding for the Aboriginal Diabetes Initiative (ADI) in next week's budget or more than 600 programs for Aboriginal Canadians living with diabetes are at risk of being shut down, according to the Canadian Diabetes Association and the National Aboriginal Diabetes Association (NADA).
Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.
House Research Institute has launched a three month nationwide outreach campaign to support the institute's educational initiative It's How You Listen That Counts.
› Verified 6 days ago
| Entity Name | Chmc Anesthesia Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831268754 PECOS PAC ID: 0446155568 Enrollment ID: O20031203000162 |
News Archive
Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at several dozen other domestic and international sites.
A study published today in the journal Cell Reports sheds new light on how the CD2AP gene may enhance Alzheimer's disease susceptibility.
The federal government must renew funding for the Aboriginal Diabetes Initiative (ADI) in next week's budget or more than 600 programs for Aboriginal Canadians living with diabetes are at risk of being shut down, according to the Canadian Diabetes Association and the National Aboriginal Diabetes Association (NADA).
Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.
House Research Institute has launched a three month nationwide outreach campaign to support the institute's educational initiative It's How You Listen That Counts.
› Verified 6 days ago
| Entity Name | Springfield Anesthesia Service Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768830 PECOS PAC ID: 0345228011 Enrollment ID: O20040709000365 |
News Archive
Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at several dozen other domestic and international sites.
A study published today in the journal Cell Reports sheds new light on how the CD2AP gene may enhance Alzheimer's disease susceptibility.
The federal government must renew funding for the Aboriginal Diabetes Initiative (ADI) in next week's budget or more than 600 programs for Aboriginal Canadians living with diabetes are at risk of being shut down, according to the Canadian Diabetes Association and the National Aboriginal Diabetes Association (NADA).
Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.
House Research Institute has launched a three month nationwide outreach campaign to support the institute's educational initiative It's How You Listen That Counts.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clara Sanders, MD 21 John St, #1, Newton, MA 02459-2347 Ph: (978) 516-8876 | Clara Sanders, MD 21 John St, #1, Newton, MA 02459-2347 Ph: (978) 516-8876 |
News Archive
Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at several dozen other domestic and international sites.
A study published today in the journal Cell Reports sheds new light on how the CD2AP gene may enhance Alzheimer's disease susceptibility.
The federal government must renew funding for the Aboriginal Diabetes Initiative (ADI) in next week's budget or more than 600 programs for Aboriginal Canadians living with diabetes are at risk of being shut down, according to the Canadian Diabetes Association and the National Aboriginal Diabetes Association (NADA).
Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.
House Research Institute has launched a three month nationwide outreach campaign to support the institute's educational initiative It's How You Listen That Counts.
› Verified 6 days ago
Dr. Antje Marianne Barreveld, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Viet Lukasz Cai, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6467 | |
Michelle Qi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Dr. Jack Mccallion, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 Fax: 617-243-6184 | |
Kenneth Aaron Garrett, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Davies G Agyekum, M.D., PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2014 Washington St, Newton, MA 02462 Phone: 617-243-6298 | |
Jaime T Lopez, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2014 Washington St, Dept Of Anesthesia, Newton, MA 02462 Phone: 617-243-6298 Fax: 617-243-6184 |